Literature DB >> 26474534

Purinergic receptor X7 mediates leptin induced GLUT4 function in stellate cells in nonalcoholic steatohepatitis.

Varun Chandrashekaran1, Suvarthi Das1, Ratanesh Kumar Seth1, Diptadip Dattaroy1, Firas Alhasson1, Gregory Michelotti2, Mitzi Nagarkatti3, Prakash Nagarkatti3, Anna Mae Diehl2, Saurabh Chatterjee4.   

Abstract

Metabolic oxidative stress via CYP2E1 can act as a second hit in NASH progression. Our previous studies have shown that oxidative stress in NASH causes higher leptin levels and induces purinergic receptor X7 (P2X7r). We tested the hypothesis that higher circulating leptin due to CYP2E1-mediated oxidative stress induces P2X7r. P2X7r in turn activates stellate cells and causes increased proliferation via modulating Glut4, the glucose transporter, and increased intracellular glucose. Using a high fat diet-fed NAFLD model where bromodichloromethane (BDCM) was administered to induce CYP2E1-mediated oxidative stress, we show that P2X7r expression and protein levels were leptin and CYP2E1 dependent. P2X7r KO mice had significantly decreased stellate cell proliferation. Human NASH livers showed marked increase in P2X7r, and Glut4 in α-SMA positive cells. NASH livers had significant increase in Glut4 protein and phosphorylated AKT, needed for Glut4 translocation while leptin KO and P2X7r KO mice showed marked decrease in Glut4 levels primarily in stellate cells. Mechanistically stellate cells showed increase in phosphorylated AKT, Glut4 protein and localization in the membrane following administration of P2X7r agonist or leptin+P2X7r agonist, while use of P2X7r antagonist or AKT inhibitor attenuated the response suggesting that leptin-P2X7r axis in concert but not leptin alone is responsible for the Glut4 induction and translocation. Finally P2X7r-agonist and leptin caused an increase in intracellular glucose and consumption by increasing the activity of hexokinase. In conclusion, the study shows a novel role of leptin-induced P2X7r in modulating Glut4 induction and translocation in hepatic stellate cells, that are key to NASH progression.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CYP2E1; Diallyl sulfide; Glucose transporter; Hexokinase; PI3K

Mesh:

Substances:

Year:  2015        PMID: 26474534      PMCID: PMC4988689          DOI: 10.1016/j.bbadis.2015.10.009

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  59 in total

Review 1.  Inflammation and fibrogenesis in steatohepatitis.

Authors:  Hideki Fujii; Norifumi Kawada
Journal:  J Gastroenterol       Date:  2012-02-07       Impact factor: 7.527

2.  Extracellular ATP induces P2X7 receptor activation in mouse Kupffer cells, leading to release of IL-1β, HMGB1, and PGE2, decreased MHC class I expression and necrotic cell death.

Authors:  Yusuke Toki; Takato Takenouchi; Hitoshi Harada; Sei-ichi Tanuma; Hiroshi Kitani; Shuji Kojima; Mitsutoshi Tsukimoto
Journal:  Biochem Biophys Res Commun       Date:  2015-02-11       Impact factor: 3.575

Review 3.  Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin.

Authors:  Peter J Havel
Journal:  Curr Opin Lipidol       Date:  2002-02       Impact factor: 4.776

Review 4.  Hepatic complications of obesity.

Authors:  Anna Mae Diehl
Journal:  Gastroenterol Clin North Am       Date:  2010-03       Impact factor: 3.806

5.  Leptin promotes the myofibroblastic phenotype in hepatic stellate cells by activating the hedgehog pathway.

Authors:  Steve S Choi; Wing-Kin Syn; Gamze F Karaca; Alessia Omenetti; Cynthia A Moylan; Rafal P Witek; Kolade M Agboola; Youngmi Jung; Gregory A Michelotti; Anna Mae Diehl
Journal:  J Biol Chem       Date:  2010-09-14       Impact factor: 5.157

Review 6.  Why do cancers have high aerobic glycolysis?

Authors:  Robert A Gatenby; Robert J Gillies
Journal:  Nat Rev Cancer       Date:  2004-11       Impact factor: 60.716

7.  CYP2E1-dependent and leptin-mediated hepatic CD57 expression on CD8+ T cells aid progression of environment-linked nonalcoholic steatohepatitis.

Authors:  Ratanesh Kumar Seth; Suvarthi Das; Ashutosh Kumar; Anindya Chanda; Maria B Kadiiska; Gregory Michelotti; Jose Manautou; Anna Mae Diehl; Saurabh Chatterjee
Journal:  Toxicol Appl Pharmacol       Date:  2013-11-07       Impact factor: 4.219

8.  Cross-talk between Notch and Hedgehog regulates hepatic stellate cell fate in mice.

Authors:  Guanhua Xie; Gamze Karaca; Marzena Swiderska-Syn; Gregory A Michelotti; Leandi Krüger; Yuping Chen; Richard T Premont; Steve S Choi; Anna Mae Diehl
Journal:  Hepatology       Date:  2013-09-30       Impact factor: 17.425

Review 9.  The inflammasome in liver injury and non-alcoholic fatty liver disease.

Authors:  Wajahat Zafar Mehal
Journal:  Dig Dis       Date:  2014-07-14       Impact factor: 2.404

10.  Insulin and leptin induce Glut4 plasma membrane translocation and glucose uptake in a human neuronal cell line by a phosphatidylinositol 3-kinase- dependent mechanism.

Authors:  Yacir Benomar; Nadia Naour; Alain Aubourg; Virginie Bailleux; Arieh Gertler; Jean Djiane; Michèle Guerre-Millo; Mohammed Taouis
Journal:  Endocrinology       Date:  2006-02-23       Impact factor: 4.736

View more
  11 in total

Review 1.  Purinergic Signalling: Therapeutic Developments.

Authors:  Geoffrey Burnstock
Journal:  Front Pharmacol       Date:  2017-09-25       Impact factor: 5.810

2.  Increased butyrate priming in the gut stalls microbiome associated-gastrointestinal inflammation and hepatic metabolic reprogramming in a mouse model of Gulf War Illness.

Authors:  Ratanesh Kumar Seth; Diana Kimono; Firas Alhasson; Sutapa Sarkar; Muayad Albadrani; Stephen K Lasley; Ronnie Horner; Patricia Janulewicz; Mitzi Nagarkatti; Prakash Nagarkatti; Kimberly Sullivan; Saurabh Chatterjee
Journal:  Toxicol Appl Pharmacol       Date:  2018-05-09       Impact factor: 4.219

3.  A Mitochondrial VDAC1-Based Peptide Greatly Suppresses Steatosis and NASH-Associated Pathologies in a Mouse Model.

Authors:  Srinivas Pittala; Yakov Krelin; Yael Kuperman; Varda Shoshan-Barmatz
Journal:  Mol Ther       Date:  2019-07-12       Impact factor: 11.454

Review 4.  The Power of Plasticity-Metabolic Regulation of Hepatic Stellate Cells.

Authors:  Parth Trivedi; Shuang Wang; Scott L Friedman
Journal:  Cell Metab       Date:  2020-11-23       Impact factor: 27.287

Review 5.  The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression.

Authors:  Geoffrey Burnstock; Gillian E Knight
Journal:  Purinergic Signal       Date:  2017-11-21       Impact factor: 3.765

Review 6.  Role of cytoglobin, a novel radical scavenger, in stellate cell activation and hepatic fibrosis.

Authors:  Le Thi Thanh Thuy; Hoang Hai; Norifumi Kawada
Journal:  Clin Mol Hepatol       Date:  2020-06-04

Review 7.  Pathophysiology of NAFLD and NASH in Experimental Models: The Role of Food Intake Regulating Peptides.

Authors:  L Kořínková; V Pražienková; L Černá; A Karnošová; B Železná; J Kuneš; Lenka Maletínská
Journal:  Front Endocrinol (Lausanne)       Date:  2020-11-26       Impact factor: 5.555

Review 8.  The Purinergic P2X7 Receptor-NLRP3 Inflammasome Pathway: A New Target in Alcoholic Liver Disease?

Authors:  Brendan Le Daré; Pierre-Jean Ferron; Thomas Gicquel
Journal:  Int J Mol Sci       Date:  2021-02-21       Impact factor: 5.923

Review 9.  The P2X7 Receptor and NLRP3 Axis in Non-Alcoholic Fatty Liver Disease: A Brief Review.

Authors:  Marco Rossato; Angelo Di Vincenzo; Claudio Pagano; Hamza El Hadi; Roberto Vettor
Journal:  Cells       Date:  2020-04-22       Impact factor: 6.600

Review 10.  Metabolic Hallmarks of Hepatic Stellate Cells in Liver Fibrosis.

Authors:  Olga Khomich; Alexander V Ivanov; Birke Bartosch
Journal:  Cells       Date:  2019-12-20       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.